Terms: = Sarcomas AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1
4 results:
1. Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile.
Sestito S; Bacci A; Chiarugi S; Runfola M; Gado F; Margheritis E; Gul S; Riveiro ME; Vazquez R; Huguet S; Manera C; Rezai K; Garau G; Rapposelli S
Eur J Med Chem; 2021 Dec; 226():113895. PubMed ID: 34624821
[TBL] [Abstract] [Full Text] [Related]
2. [Screening and identification of novel drug-resistant genes in CD133+ and CD133- lung adenosarcoma cells using cDNA microarray].
Wang H; Zheng S; Tu Y; Zhang Y
Zhongguo Fei Ai Za Zhi; 2014 Jun; 17(6):437-43. PubMed ID: 24949682
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
Al-Dosari M; Zhang G; Knapp JE; Liu D
Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptional regulatory elements for basal expression of cytochrome P450IIC genes.
Venepally P; Chen D; Kemper B
J Biol Chem; 1992 Aug; 267(24):17333-8. PubMed ID: 1324931
[TBL] [Abstract] [Full Text] [Related]
